HOME >> BIOLOGY >> NEWS
Other highlights of the March 17 issue of JNCI

HPV in Oral Cells May Be a Risk Factor for Head and Neck Cancer

Infection with a high-risk type of human papillomavirus (HPV) in oral epithelial cells may be an independent risk factor for head and neck cancer, according to a new study.

HPV has been associated with the development of head and neck cancers. Elaine M. Smith, Ph.D., of the University of Iowa, and colleagues conducted a casecontrol study to determine the risk factors for head and neck cancer in relation to HPV infection. The authors detected high-risk HPV types in oral cells from 22.9% of the 201 case patients and 10.8% of the 333 control subjects. Individuals with high-risk HPV types, but not individuals with nononcogenic or low-risk HPV types, had an increased risk of head and neck cancer compared with HPV-negative individuals.

High-risk HPV types detected in oral exfoliated cells were predictive of high-risk HPV types in tumor tissue. The authors found a synergistic effect between detection of high-risk HPV and heavy alcohol consumption, but only an additive effect between detection of high-risk HPV and tobacco use. The authors conclude that HPV testing using an oral rinse may provide an early biomarker for HPV-associated head and neck cancer.

Contact: Dan McMillan, University of Iowa, 319-335-6835, daniel-mcmillan@uiowa.edu

Letrozole Extends Time to Tumor Progression in Mouse Model

In a mouse model of human breast cancer, the drug letrozole more effectively extends time to tumor progression than tamoxifen or various combinations and dosing schedules of tamoxifen plus letrozole.

Clinical data from patients with estrogen receptor-positive breast cancer suggest that aromatase inhibitors, such as letrozole, are more effective and better tolerated than the antiestrogen tamoxifen. To investigate ways to optimize treatment using letrozole and tamoxifen, Brian J. Long and Angela M. Brodie, Ph.D.
'"/>

Contact: Katherine Arnold
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
16-Mar-2004


Page: 1 2 3 4

Related biology news :

1. Other highlights in the September 1 JNCI
2. Other highlights in the August 18 JNCI
3. Other highlights in the August 4 JNCI
4. Other highlights in the July 7 JNCI
5. Other highlights in the June 16 JNCI
6. Other Highlights in the June 2 JNCI
7. Other highlights in the May 19 JNCI
8. Other highlights in the May 5 JNCI
9. Other highlights in the March 3 issue of JNCI
10. Other highlights in the February 18 issue of JNCI
11. Other highlights in the February 4 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... manufacture lifesaving mature red blood cells from stem cells. The red blood ... blood cells, under strictly controlled conditions, for transfusion therapy and replaces the need ...
(Date:1/23/2020)... ... January 23, 2020 , ... Asymmetrex LLC ... Manufacturing Institute (ARMI). Headquartered in Manchester, New Hampshire, ARMI is the 12th ... organizations from industry, government, academia and the non-profit sector to develop next-generation ...
(Date:1/22/2020)... ... January 21, 2020 , ... Lifecycle Biotechnologies announces the new line of high purity ... needs based on their process requirements and accurately weighed to 0.001 of a gram. The ... Salts , Sugars , Carbohydrates , Phosphates , ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... ... February 18, 2020 , ... Shoreline Biome, a ... strain level, recently unveiled a novel DNA isolation product. , Shoreline Rapid Prep ... high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40 kB from ...
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... ... process solutions for the life sciences industry, today announced the opening of a ... Nagamura, Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new office ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... the successful results from a long-term follow-up clinical study of outpatient L4-L5 ... device (INSPAN LLC). Unlike extension block design, the Inspan device fixates the ...
(Date:2/10/2020)... LAS VEGAS (PRWEB) , ... February 10, 2020 , ... ... Cell Training Course March 13-14th, 2020 in Las Vegas. The course is hands ... procedure too. , For the past few years, the Comprehensive Stem Cell Training Course ...
Breaking Biology Technology:
Cached News: